Robert Kirkcaldy, MD, MPH

Centers for Disease Control and Prevention
Division of STD Prevention
1600 Clifton Road, E-02
Atlanta, GA
USA 30333
rkirkcaldy@cdc.gov

Biographical Sketch:
2010-present -- Medical Officer, Division of STD Prevention, CDC, Atlanta, GA 2008-2010 -- Epidemic Intelligence Officer, Division of STD Prevention, CDC, Atlanta, GA 2004-2008 -- Internal Medicine and Psychiatry Hospitalist, Shady Grove Adventist Hospital, Rockville, MD and Montgomery General Hospital, Olney, MD Publications Kirkcaldy RD, Augostini P, Asbel LE, et al. Trichomonas vaginalis Antimicrobial Resistance in Six US Cities, STD Surveillance Network, 2009–2010. (in preparation) Katz AR, Komeya AY, Soge OO, et al. Neisseria gonorrhoeae with high-level resistance to azithromycin: case-report of the first isolate identified in the United States. (under review) Goldstein E, Kirkcaldy RD, Reshef D, et al. Factors Related to the Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobials in Neisseria gonorrhoeae in the United States. (under review) Kirkcaldy RD, Mika J, Newman LM, et al. Bacterial Vaginosis, Alterations in Vaginal Flora and HIV Genital Shedding among HIV-1 Infected Women in Mozambique. Southern African Journal of HIV Medicine 2011; 40:22–24. Kirkcaldy RD, Ballard R, Dowell D. Gonococcal Resistance: Are Cephalosporins Next? Current Infectious Disease Reports 2011; 13(2):196-204. Kirkcaldy RD, Su JR, Taylor M, et al. Epidemiology of Syphilis among Hispanic Women and Associations with Congenital Syphilis, Maricopa County, Arizona. Sexually Transmitted Disease (Epub Feb 2011) Government Reports CDC. Gonorrhea section of Sexually Transmitted Disease Surveillance 2010. Atlanta: US Department of Health and Human Services; 2011 (in preparation). CDC. Trends in Cephalosporin Susceptibility among Neisseria gonorrhoeae Isolates — United States, January 2000–June 2010. MMWR 2011; 60(26):873-877. CDC. Neisseria gonorrhoeae Infections with High Minimum Inhibitory Concentrations to Azithromycin — San Diego County, California, 2009. MMWR 2011; 60(18):579-581. Presentations Kirkcaldy RD. Surveillance of Neisseria gonorrhoeae Antibiotic Resistance. Antimicrobial Resistance: Biology and Population Dynamics Symposium. The Center for Communicable Disease Dynamics at Harvard School of Public Health. October 3, 2011. Kirkcaldy RD, Murray EL, Del Rio C, Hall G, Hook EW, Whittington WL, Papp J, Weinstock HS. Cephalosporin susceptibility of Neisseria gonorrhoeae isolates in the United States, 2000–2010. 19th Conference of the International Society of STD Research, Quebec, Canada, July 11, 2011. Kirkcaldy RD, Weinstock HS. US response to the emergence of cephalosporin resistant gonorrhea. Meeting of the International Collaboration of Gonococci, Quebec, Canada, July 10, 2011. Kirkcaldy RD. Epidemiology and Drug Resistance in Trichomonas vaginalis in the United States. 59th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, GA, November 6, 2010.